CVS Health Corp. (NYSE:CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.
Adjusted earnings of $1.09 per share also beat the analyst estimate of 99 cents, decreased from $1.19 in the prior year.
CVS Health reaffirmed its fiscal 2026 adjusted earnings guidance of $7.00-$7.20 per share versus the Street consensus of $7.17. The company said the guidance highlights our strong position for 2026.
The company updated its cash flow from operations guidance to at least $9.0 billion from at least $10.0 billion.
CVS sees fiscal 2026 revenue of at least $400 billion versus the consensus of $409.77 billion, with adjusted operating income of between $15.07–$15.41 billion.
Analyst View
Given investor fears around Medicare Advantage headwinds in 2027 and increased scrutiny in …